Billy Cho | Chief Financial Officer |
Samantha Du | Founder, Chairperson and Chief Executive Officer |
Josh Smiley | Chief Operating Officer |
Rafael Amado | President, Head of Global Oncology Research and Development |
Harald Reinhart | President, Head of Global Development, Neuroscience, Autoimmune and Infectious Diseases |
Jonathan Wang | Chief Business Development |
Michael Yee | Jefferies |
Anupam Rama | J.P. Morgan |
Yigal Nochomovitz | Citi |
Jonathan Chang | SVB Leerink |
Ziyi Chen | Goldman Sachs |
Seamus Fernandez | Guggenheim Partners |
Yang Huang | Credit Suisse |
Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab Full Year and Fourth Quarter 2022 Financial Results Conference Call. [Operator Instructions] As a reminder, today's call is being recorded.
It's now my pleasure to turn the floor over to Billy Cho, Chief Financial Officer of Zai Lab, who will make introductory comments.
Thank you, operator.